Huang Baoyi, Huang Shengchao, Yan Zeming, Li Jialun, Zhang Yuanqi
Department of Breast Surgery, Affiliated Hospital of Guangdong Medical University, Zhanjiang, Guangdong Province, People's Republic of China.
Discov Oncol. 2025 May 8;16(1):700. doi: 10.1007/s12672-025-02496-1.
Breast cancer remains a significant global health challenge, with lung metastasis presenting critical barriers to effective treatment and patient survival. This study conducts the first comprehensive bibliometric and visualized analysis of lung metastasis research in breast cancer from 2000 to 2024, illustrating evolving research trends and collaboration patterns in this critical area. Utilizing data from the Web of Science Core Collection, we employed bibliometric tools such as VOSviewer and CiteSpace to assess publication trends, international collaborations, influential institutions, authors, and keyword dynamics. Our findings reveal a steady increase in annual publications, peaking in 2021, with a significant concentration of research emerging from the USA and China, alongside key insights into molecular mechanisms such as epithelial-mesenchymal transition and immunotherapy. Notably, genes like ERBB2 and ESR1 were identified as pivotal in the metastatic process, highlighting potential therapeutic targets. This study not only illuminates the current landscape of breast cancer lung metastasis research but also underscores the necessity for interdisciplinary collaboration to enhance understanding and treatment strategies for this lethal condition.
乳腺癌仍然是一项重大的全球健康挑战,肺转移对有效治疗和患者生存构成关键障碍。本研究首次对2000年至2024年乳腺癌肺转移研究进行了全面的文献计量和可视化分析,阐明了这一关键领域不断演变的研究趋势和合作模式。利用科学网核心合集的数据,我们使用了文献计量工具,如VOSviewer和CiteSpace,来评估出版趋势、国际合作、有影响力的机构、作者和关键词动态。我们的研究结果显示,年度出版物稳步增加,在2021年达到峰值,美国和中国的研究高度集中,同时对上皮-间质转化和免疫治疗等分子机制有了关键见解。值得注意的是,ERBB2和ESR1等基因被确定在转移过程中起关键作用,突出了潜在的治疗靶点。这项研究不仅阐明了乳腺癌肺转移研究的现状,还强调了跨学科合作对于增进对这种致命疾病的理解和治疗策略的必要性。
Heliyon. 2024-12-16
Drug Des Devel Ther. 2024
Perioper Med (Lond). 2025-1-30
Adv Exp Med Biol. 2025
Signal Transduct Target Ther. 2024-8-2
Int J Mol Sci. 2023-10-18